CDMO Education Centre

Scaling-up Versus Scaling-out: Here’s What You Need To Know

close

Categories

See More

Subscribe to Email Updates

Popular Stories

The Canadian Regulatory System for Cell and Gene Therapies Apr 13, 2022
Understanding the Role of the Quality Unit in Good Manufacturing Practices Nov 29, 2021
Viral Aggregation in Downstream Processing of Lentiviral Vectors May 11, 2020
Planning Is Everything - Quality Control Testing in Cell and Gene Therapy Oct 30, 2019
What Are Change Controls and Why Are They Important in GMP? Dec 08, 2021
Categories | Subscribe | Popular
05 Jul 2022

Scaling-up Versus Scaling-out: Here’s What You Need To Know

A lot of CDMO customers ask about scale-out and scale-up, and what app...

21 May 2021

Scaling-Up Production of Pluripotent Stem Cells Part 1: Begin with the End in Mind

Many emerging cell and gene therapies are aimed at using cell replacem...

30 Oct 2019

Concentration and Reformulation of Cellular Immunotherapies – A Major Downstream Processing Step

Cellular immunotherapies (e.g. CAR-T cells) are primarily used as an a...

30 Oct 2019

How To Scale-Up Lentiviral Vector Production Part 2: Considerations for Downstream Processing

In Part 1 of our series on lentiviral vector (LVV) manufacturing we co...

29 Oct 2019

How to Scale-Up Lentiviral Vector Production Part 1: Considerations for Upstream Processing

Lentiviral vectors (LVV) are a key component in the production of cell...

24 Oct 2019

What is a Bioreactor and How is it Used in Cell and Gene Therapy?

Simply put, a bioreactor is a stand-alone cell culture vessel enabled ...

Tell us what you thought about this post.
Business people meeting around table in modern space

Subscribe to our blog.

Receive updates on the latest trends in cell & gene therapy.

Subscribe to Email Updates

© 2023 All Rights Reserved